bioRxiv Science⌕ Search

Biology subjects

Bahloul, A.

Publications and source records attributed to Bahloul, A..

2 recordsLinked to original sources

Comparison of the 4-helix bundle domains of perilipin 3 and perilipin 4 identifies features that contribute to lipid droplet binding

The perilipins generally represent the most abundant lipid droplet (LD) surface proteins in mammalian cells and can target LD subpopulations within the same cell. They are characterized by a conserved organization of disordered and folded regions, as well as a number of divergent features, which contribute to differences in perilipin function and LD targeting. Here, we focus on the C-terminal 4-helix bundle (4HB) domain that is present in all perilipins except for PLIN1. Using biochemical and in silico approaches, we show that the 4HB of PLIN3 is a stably folded domain and interacts with lipid surfaces in vitro and with LDs in model cells. The {beta}-subdomain at the bottom of the helical bundle is required for the binding to LDs, but not for the 4HB stability, suggesting that this region may promote direct interaction with the LD surface. In agreement, the 4HB of PLIN4, which does not contain an {beta}- subdomain, does not bind to LDs. Overall, our work shows that small differences in perilipin structural features impact their differential targeting to LDs.

biochemistry↗

Endothelial Function: A Novel Marker to Evaluate the Prognosis of Heart Failure with Reduced Ejection Fraction

BackgroundEndothelial function, a key determinant of prognosis in heart failure with reduced ejection fraction (HFrEF), is still frequently under-assessed in clinical practice. The present study aimed to assess endothelial function in patients with HFrEF and investigate its association with echography and hemodynamics over a 3-month medical treatment. Additionally, this study aimed to investigate the association between changes in endothelial function and the incidence of cardiovascular rehospitalizations or deaths. MethodsThis prospective longitudinal study included 120 patients with HFrEF. Hemodynamic parameters were assessed using impedance cardiography. Endothelial function was evaluated using digital thermal monitoring to calculate the Endothelial Quality Index (EQI) at baseline and after 3 months. Patients were followed for 12 months. ResultsThe mean age was 61.9 {+/-} 10.2 years, with a sex ratio of 5:1. 42.5% of patients tend to experience endothelial dysfunction at baseline. After 3 months of optimized therapy, EQI improved significantly (p<0.001), correlating with improved echography and hemodynamic parameters. Over 12 months, there were 5 deaths (4.16%) and 44 heart failure rehospitalizations (36.6%), predominantly among those with severe endothelial dysfunction (p=0.008). Improved EQI was associated with reduced mortality (AUC = 0.82) and rehospitalization risk (AUC = 0.837). A {Delta}EQI [&ge;] 0.2 predicted better prognosis (HR: 0.157, 95% CI: 0.054-0.454, p=0.001). ConclusionPatients with HFrEF exhibited endothelial dysfunction. The improvement in endothelial function after an optimized treatment is associated with an enhancement in echography and hemodynamic parameters. Additionally, endothelial function was a strong prognostic marker.

physiology↗